Clin2
NCT07583992Possibly a fitNot yet recruiting

Chinese herbal medicine added to standard pneumonia treatment

Mild to ModerateCommunity-Acquired Pneumonia (CAP)Antibiotic TherapyIntravenousHospitalisation

Part of Infections, Lungs & breathing clinical trials.

This study tests whether adding NRICM102, a traditional Chinese medicine, to standard antibiotic treatment helps hospitalized patients with community-acquired pneumonia (a lung infection acquired outside a hospital) recover better. You would receive the herbal medicine by mouth along with your regular antibiotics.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
150 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • Age 18–85 years
  • Hospitalized with community-acquired pneumonia confirmed by chest X-ray and fever or cough with abnormal blood work
  • Started on antibiotics less than 24 hours ago
  • Able to swallow and take oral medication
  • Not in intensive care and not needing dialysis
  • No recent hospitalization, HIV infection, cancer, or serious lung/heart/kidney disease

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06859450Not yet recruiting· Phase 2/Phase 3
Local antibiotics for community acquired pneumonia

This trial tests whether giving antibiotics directly into the lungs can help treat severe pneumonia. If you have been hospitalized with pneumonia and have a high fever or high inflammation levels, you may be eligible.

NCT06747325Not yet recruiting
Herbal Granules for Pneumonia in Older Adults

This trial tests a Chinese herbal medicine (Fei Re Qing Granules) for older adults recently hospitalized with pneumonia. It aims to see if the granules help speed recovery when added to standard care.

NCT06669403Not yet recruiting· Phase 1
Testing OPT101 for pneumonia with sepsis

This trial tests a new medicine (OPT101) for people hospitalized with pneumonia and sepsis—where a lung infection causes body-wide inflammation and low oxygen. It aims to help patients who need extra oxygen but are not yet on a breathing machine.

Denver, Colorado
NCT06690203Enrolling by invitation
Herbal Medicine for Chronic Lung Conditions (NRICM102)

This trial tests an herbal medicine called NRICM102 for people with chronic cough and long-term lung diseases like asthma or COPD. It aims to see if the medicine is safe and helps improve symptoms.

Taichung, No.1650, Taiwan Boulevard Sect. 4
NCT06220019Not yet recruiting
Chinese herbal medicine for hospitalized pneumonia patients

This trial studies whether Chinese herbal medicine can help people hospitalized with pneumonia. It compares the herbal treatment to usual care to see if it improves recovery.

NCT07726095Not yet recruiting
Traditional Chinese medicine for antibiotic-resistant pneumonia

This trial is testing whether a special traditional Chinese medicine formula can help treat pneumonia caused by bacteria that don't respond to many standard antibiotics. If you are hospitalized with this type of pneumonia, the study aims to find a new treatment option to help you fight the infection.

Zhengzhou, Henan

Hear when a new Antibiotic Therapy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.